Maia Strategy provides its Diagnostics clients with the insights required to grow and defend market share, in an industry that has grown increasingly more sophisticated and highly-regulated. Leading diagnostics companies turn to Maia Strategy when evaluating geographic expansion strategies, M&A opportunities, and product rationalization initiatives.
Maia helps its clients to develop winning strategies for the following markets and product areas:
- Point-of-Care Testing (POCT)
- In-Vitro Laboratory Based Testing (both clinical and academic)
- Reference Laboratories
- NIPT
- Sequencing
- Digital Pathology
Our primary research provide clients with insights from hard-to-reach decision-makers, including care providers and lab directors at Centers of Excellence, government regulatory staff, clinical trial personnel, and academic researchers.
Related Case Studies
Preparing the Right Competitive Response to New Diagnostic Product Entry